NCT03211195View on ClinicalTrials.gov

Sotagliflozin Bioequivalence Study

PHASE1CompletedINTERVENTIONAL

Enrollment

76

Participants

Timeline

Start Date

June 29, 2017

Primary Completion Date

August 22, 2017

Study Completion Date

August 22, 2017

Conditions

Type 2 Diabetes Mellitus

Interventions

DRUG

Sotagliflozin (SAR439954)

"Pharmaceutical form: tablet~Route of administration: oral"

Trial Locations (1)

33014

Investigational Site Number 840001, Miami

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Sanofi

INDUSTRY